SCHEMBL13596295

SCHEMBL13596295

CC(C)(C)Nc1ccc(COC(=O)Nc2ccc(COC(=O)C(C)(C)C)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
NAMPT P43490 1/20 0.48
POLB P06746 1/20 0.46
TP53 P04637 1/20 0.43
MAPT P10636 1/20 0.43
KDM1A O60341 2/20 0.42
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
ROCK2 O75116 2/20 0.41
RCOR1 Q9UKL0 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12157064 0.91 KMT2A (0.43) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL19400599 0.88 MEN1 (0.55) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL1753759 0.86 MEN1 (0.46) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL1753584 0.85 MEN1 (0.46) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL19592560 0.85 SMN1; SMN2 (0.55) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL19901428 0.84 MEN1 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL1753582 0.84 MEN1 (0.54) MEN1KMT2ASMN1; SMN2L3MBTL1NAMPT
SCHEMBL23318363 0.81 KMT2A (0.41) MEN1KMT2ASMN1; SMN2L3MBTL1MAPT
SCHEMBL22907349 0.80 MEN1 (0.42) MEN1KMT2ASMN1; SMN2L3MBTL1POLB
SCHEMBL18792738 0.80 MEN1 (0.42) MEN1KMT2ASMN1; SMN2L3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11052155-B2 Conjugates of CC-1065 analogs and bifunctional linkers SYNTARGA BV (NL) 2021-07-06 US disclosed
US-20180133316-A9 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2018-05-17 US disclosed
US-9815784-B2 CC-1065 analogs and their conjugates SYNTARGA B.V. (NL) 2017-11-14 US disclosed
US-20170274090-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers SYNTARGA BV (NL) 2017-09-28 US disclosed
US-8940784-B2 Water-soluble CC-1065 analogs and their conjugates SYNTARGA B.V. (NL) 2015-01-27 US disclosed
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates Georg-August-Universität Göttingen Stiftung öffentlichen Rechts (ohne Bereich Humanmedizin) (DE) 2009-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170274090-A1 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L MEN1 1237/4885KMT2A 1026/4885SMN1; SMN2 645/4885
US-20090318668-A1 Water-Soluble CC-1065 Analogs and Their Conjugates PCNA, DCK, BAD MEN1 2080/4885KMT2A 1501/4885SMN1; SMN2 383/4885
US-20180133316-A9 Novel Conjugates of CC-1065 Analogs and Bifunctional Linkers PCNA, DCLRE1A, CDC5L MEN1 1237/4885KMT2A 1026/4885SMN1; SMN2 645/4885
US-11052155-B2 Conjugates of CC-1065 analogs and bifunctional linkers PCNA, DCLRE1A, CDC5L MEN1 1247/4885KMT2A 1003/4885SMN1; SMN2 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.